Last Updated : Friday, July 10, 2020 19:04:11

News of Healthcare Services in Gujarat

UNICHEM LABS gets USFDA nod to sell tablets to treat pain, spasms

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing Indian company UNICHEM LABORATORIES LTD said of having got USFDA (US Food & Drugs Administration) nod to sell medicines to cure pain, spasms and muscular rigidity. In a press-release as attached and enclosed with the

STRIDES PHARMA gets USFDA nod to sell medicine to treat tension, headache

BANGALORE / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Bangalore headquartered pharmaceutical products manufacturing Indian company Strides Pharma Sciences Ltd said of having got nod from USFDA (US Food and Drugs Administration) to sell medicine to treat tension (or muscle concentration) and headache. In a press-release titled,

LUPIN recalls blood-sugar control tablets used by diabetics, from US Markets

BALTIMORE (MARYLAND, US) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing Indian company Lupin Ltd’s US Subsidiary Lupin Pharmaceuticals Inc., said of having voluntarily recalled its Metaformin Hydrochloride Extended Release Tablets USP of 500 mg (milligram) and 100 mg dosage value from

CADILA HEALTH gets Mexican Regulators’s nod to study COVID19 cure drug

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare services providing and healthcare & pharmaceutical product manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got approval from COFERIS, Mexico to study Desidustat in the management of COVID19. In a press-release

In US, GRANULES PHARMA recalls tablets to control blood-sugar levels

CHANTILLY (VIRGINIA, US) / HYDERABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Hyderabad headquartered Granules India Ltd said of its wholly owned subsidiary and US arm Granules Pharmaceuticals Inc., having issued voluntary nationwide recall in US markets of Metformin Hydrochloride Extended Release Tablets USP, 750 mg

CADILA HEALTH gets DCGI-CDSCO nod for COVID19 vaccine’s human trials

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Pankaj Patel led healthcare service provider and pharmaceutical & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd claimed of having successfully completed preclinical development of the company’s vaccine for COVID19 – ZyCoV-D and having received permission

Dr REDDY’s partners with FUJIFILM to mfr & sell Favipiravir to treat COVID19

HYDERABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceutical products manufacturing Indian company Dr. Reddy’s Laboratories Ltd said of having partnered with Japan’s FUJIFILM and Global Response Aid for development, manufacture and sales of Avigan® (generic version of Favipiravir), a potential treatment to treat

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat bacterial infections

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell tablets to cure bacterial infections. In a press-release titled, “Alembic Pharmaceuticals receives USFDA

8K MILES announced Cloud Tech & Consulting Services for Life Sciences Cos

PLEASANTON (CALIFORNIA, US) / CHENNAI / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Chennai headquartered Internet Software & Services sector company 8K MILES SOFTWARE SERVICES LTD announced launch of full-fledged operations of Healthcare Triangle Inc., as a subsidiary of 8K Miles Software Services Inc. USA by combining

ALEMBIC PHARMA gets USFDA nod to sell medicine to treat risk of stroke

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat risk of stroke and allied illness. In a press-release titled, “Alembic Pharmaceuticals receives USFDA Tentative

BIOCON collaborates with DKSH for distribution in South East Asian Markets

BANGKOK (THAILAND) / SINGAPORE / BENGALURU / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Dr Kiran Mazumdar Shaw led and Bengaluru headquartered Biotechnology and pharmaceutical products manufacturing Indian company Biocon Ltd said of having collaborated with Zurich (Switzerland) headquartered DKSH (DiethelmKellerSiberHegner) Holding, a market expansion services providing

CIPLA gets DCGI nod to sell CIPREMI (Remdesivir lyophilized powder for injection)

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, pharmaceutical products manufacturing Indian company Cipla Ltd said of having got nod from USFDA to sell Cipremi (remdesivir lyophilized powder for injection 100 mg), which is an approved emergency use authorization (EUA) treatment for patients with severe COVID19 disease. In

GLENMARK gets Indian Regulator’s nod to make & sell COVID19 treatment drug

MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Glenmark Pharmaceuticals Ltd said of having emerged as the first pharmaceutical company in India to have got regulatory approval for manufacturing & marketing oral antiviral Favipiravir, for treatment of mild to moderate COVID19 disease.

Dr REDDY’s LAB launches medicine to treat prostate cancer in US Market

PRINCETON (NEW JERSEY, US) / HYDERABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Hyderabad headquartered Reddy family owned and managed pharmaceuticals products manufacturing Indian company Dr. Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat prostate

Alembic JVC ALEOR DERMA gets USFDA nod to sell gel to treat pimples, cysts

VADODARA (BARODA) / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Amin family owned 100 years old pharmaceutical products manufacturing Indian company Alembic Pharmaceuticals Ltd said of having announced its joint-venture company Aleor Dermaceuticals having received USFDA (US Food & Drugs Administration) nod to sell

GLENMARK PHARMA gets USFDA nod to sell medicine to treat cough, cold

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Glenmark Pharmaceuticals Ltd said of having got a final nod from USFDA to sell medicine to treat cough and cold. In a press-release titled, “Glenmark Pharmaceuticals receives ANDA approval for Fingolimod Capsules, 0.5 mg”

Do NOT follow this link or you will be banned from the site!